Načítá se...
PARTNER 2A & SAPIEN 3: TAVI for intermediate risk patients
Transcatheter aortic valve implantation (TAVI) is currently indicated for patients with severe symptomatic aortic stenosis who are unfit for surgery or when the surgical risk is high. Thanks to the increasing experience of surgeons, better patient selection, and substantial improvements in device te...
Uloženo v:
| Vydáno v: | Glob Cardiol Sci Pract |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Magdi Yacoub Heart Foundation
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5584311/ https://ncbi.nlm.nih.gov/pubmed/31463304 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21542/gcsp.2016.33 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|